Diagnosis is difficult, and many cases are missed in everyday practice ...

Lewy body dementia (LBD) is a type of dementia caused by abnormal protein deposits in the brain, called Lewy bodies. The ...

Please provide your email address to receive an email when new articles are posted on . In this video, James E. Galvin, MD, MPH, discusses the SHIMMER study, presented at the Alzheimer’s Association ...

Adults with mild to moderate dementia with Lewy bodies had slowed decline in four clinical signals with the oral, brain-penetrant, small module therapeutic zervimesine vs. placebo at 6 months, ...

(RTTNews) - CervoMed Inc. (CRVO) has announced positive 32-week data from the Extension phase of its phase IIb RewinD-LB trial of oral investigational drug Neflamapimod for the treatment of dementia ...

Early detection of Alzheimer’s disease-related changes in Parkinson's disease and dementia with Lewy bodies could be made possible by monitoring the amyloid-β (Aβ) and phosphorylated tau (p-tau) ...

Penn Medicine researchers will advance their understanding of the underlying causes of cognitive decline in individuals with Lewy body diseases, like Parkinson's, and identify biomarkers that predict ...

Add Yahoo as a preferred source to see more of our stories on Google. Like most variations of dementia, LBD is a complex neurodegenerative disorder, and the exact causes are not yet completely ...

Lewy body dementia is a neurodegenerative syndrome characterised by progressive cognitive decline, parkinsonism and visual hallucinations. Genetic studies indicate heritability accounts for up to one ...

On April 7, 2026, CervoMed announced that its representatives would present key aspects of the neflamapimod clinical program at the 2026 Lewy Body Dementia Association Annual Meeting in Atlanta, ...

To recreate in the laboratory the formation of Lewy bodies as they would occur in a Parkinson’s patient, two ingredients are required: the protein α-synuclein and the participation of the immune ...

Lewy body dementia is a progressive neurodegenerative disorder brought on by an excess of the protein alpha-synuclein in the brain. These deposits, known as Lewy bodies, can inhibit the production of ...